Monique Balthazar1, Idiatou Diallo2, Victoria M Pak3. 1. Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. 2. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. victoria.m.pak@emory.edu.
Abstract
PURPOSE: Sleep disturbances are prevalent among patients with human immunodeficiency virus (HIV), even those who are being treated on antiretroviral therapy. It is important to understand the metabolomic mechanisms underlying sleep disturbances among people living with HIV (PLWH). METHODS: A review of recent literature was performed to explore the use of metabolomics in understanding sleep among PLWH. RESULTS: We found only two studies that used metabolomics to explore sleep health among PLWH. CONCLUSION: This paper reviews common sleep disorders in HIV, the existing metabolomic studies that may explain the relationship, and implications for future research. The use of metabolomics in exploring sleep disorders among PLWH will help to elucidate mechanistic links to improve patient outcomes.
PURPOSE:Sleep disturbances are prevalent among patients with human immunodeficiency virus (HIV), even those who are being treated on antiretroviral therapy. It is important to understand the metabolomic mechanisms underlying sleep disturbances among people living with HIV (PLWH). METHODS: A review of recent literature was performed to explore the use of metabolomics in understanding sleep among PLWH. RESULTS: We found only two studies that used metabolomics to explore sleep health among PLWH. CONCLUSION: This paper reviews common sleep disorders in HIV, the existing metabolomic studies that may explain the relationship, and implications for future research. The use of metabolomics in exploring sleep disorders among PLWH will help to elucidate mechanistic links to improve patient outcomes.
Authors: Lucía Gallego; Pablo Barreiro; Rafael del Río; Daniel González de Requena; Apolinar Rodríguez-Albariño; Juan González-Lahoz; Vincent Soriano Journal: Clin Infect Dis Date: 2004-01-09 Impact factor: 9.079
Authors: Eliane Borges-Almeida; Helaine M B P M Milanez; Maria Marluce S Vilela; Fernanda G P Cunha; Beatriz M Abramczuk; Suiellen C Reis-Alves; Konradin Metze; Irene Lorand-Metze Journal: BMC Infect Dis Date: 2011-02-03 Impact factor: 3.090
Authors: B Payne; T J Chadwick; A Blamire; K N Anderson; J Parikh; J Qian; A M Hynes; J Wilkinson; D A Price Journal: HIV Med Date: 2017-03-01 Impact factor: 3.180
Authors: Leonard Ngarka; Joseph Nelson Siewe Fodjo; Esraa Aly; Willias Masocha; Alfred K Njamnshi Journal: Front Immunol Date: 2022-01-13 Impact factor: 8.786